Combined Antioxidant Therapy Against Myocardial Reperfusion Injury. Phase I Study.

NCT05215743 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Acute Myocardial Infarction
Ischemia-reperfusion Injury
Reperfusion Injury, Myocardial
Reperfusion Arrhythmias
Reperfusion Injury

Interventions

DRUG: Antioxidant therapy
DRUG: NaCl 0.9%

Sponsor

University of Chile

Collaborators

[object Object]